US20260131099
2026-05-14
Human necessities
A61M16/0683
This patent application describes an innovative Continuous Positive Airway Pressure (CPAP) mask integrated with End-Tidal Carbon Dioxide (ETCO2) monitoring, designed for emergency medical services and healthcare settings. The device allows simultaneous CPAP therapy and ETCO2 monitoring, streamlining respiratory care and enhancing patient comfort. By integrating these functions, the need for multiple masks and oxygen sources is eliminated, simplifying treatment processes and improving efficiency, particularly in pre-hospital and non-clinical environments.
The CPAP mask is engineered to deliver a constant flow of pressurized air to patients with respiratory distress, preventing airway collapse and improving oxygenation. Integrated within the mask is an ETCO2 filtration and monitoring mechanism that continuously measures exhaled carbon dioxide levels. This real-time monitoring provides critical data for diagnosing and managing respiratory conditions, making it a vital tool in emergency care settings.
The integrated design significantly reduces equipment complexity by requiring only a single oxygen source for both CPAP therapy and ETCO2 monitoring. This eliminates the need for multiple oxygen lines, simplifying the setup and reducing potential errors during treatment. The ergonomic design of the mask ensures it can be quickly applied and adjusted to fit various facial structures, enhancing patient comfort and tolerance.
This integrated system offers several advantages over existing solutions, including streamlined patient care, reduced setup time, enhanced patient comfort, and real-time monitoring for faster clinical decision-making. The cost-effectiveness of combining two systems into one device also results in significant savings for healthcare providers and EMS agencies, while simplified training requirements make it easier for providers to use the device effectively.